Ct, Polymorphism, and Laboratory Biomarkers for Predicting Chemosensory Dysfunctions and Mortality in COVID-19

Overview

Journal Future Sci OA

Specialty Biotechnology

Date 2023 Mar 31

PMID 36999046

Authors

Shukur Wasman Smail

Esmaeil Babaei

Kawa Amin

Affiliations

Soon will be listed here.

Abstract

Aim: Patients with COVID-19 often experience chemosensory dysfunction. This research intends to uncover the association of RT-PCR Ct value with chemosensory dysfunctions and SpO. This study also aims to investigate Ct, SpO, CRP, D-dimer, and -607 T/G polymorphism in order to find out predictors of chemosensory dysfunctions and mortality.

Materials & Methods: This study included 120 COVID-19 patients, of which 54 were mild, 40 were severe and 26 were critical. CRP, D-dimer, RT-PCR, and polymorphism were evaluated. : Low Ct was associated with SpO dropping and chemosensory dysfunctions. T/G polymorphism did not show an association with COVID-19 mortality; conversely, age, BMI, D-dimer and Ct values did.

Citing Articles

Decoding the intricacies: a comprehensive analysis of microRNAs in the pathogenesis, diagnosis, prognosis and therapeutic strategies for COVID-19.

Smail S, Hirmiz S, Ahmed A, Albarzinji N, Awla H, Amin K Front Med (Lausanne). 2024; 11:1430974.

PMID: 39434774 PMC: 11492531. DOI: 10.3389/fmed.2024.1430974.

Beyond prediction: unveiling the prognostic power of μ-opioid and cannabinoid receptors, alongside immune mediators, in assessing the severity of SARS-CoV-2 infection.

Tavakoli-Yaraki M, Abbasi A, Pishkenari F, Baranipour S, Jahangirifard A, Mirtajani S BMC Infect Dis. 2024; 24(1):398.

PMID: 38609845 PMC: 11015610. DOI: 10.1186/s12879-024-09280-6.

Unveiling COVID-19 Secrets: Harnessing Cytokines as Powerful Biomarkers for Diagnosis and Predicting Severity.

Wolszczak-Biedrzycka B, Dorf J, Wojewodzka-Zelezniakowicz M, Zendzian-Piotrowska M, Dymicka-Piekarska V, Matowicka-Karna J J Inflamm Res. 2023; 16:6055-6070.

PMID: 38107380 PMC: 10723593. DOI: 10.2147/JIR.S439217.

References

Suleyman G, Fadel R, Malette K, Hammond C, Abdulla H, Entz A . Clinical Characteristics and Morbidity Associated With Coronavirus Disease 2019 in a Series of Patients in Metropolitan Detroit. JAMA Netw Open. 2020; 3(6):e2012270. PMC: 7298606. DOI: 10.1001/jamanetworkopen.2020.12270. View

Huyut M, Huyut Z . Forecasting of Oxidant/Antioxidant levels of COVID-19 patients by using Expert models with biomarkers used in the Diagnosis/Prognosis of COVID-19. Int Immunopharmacol. 2021; 100:108127. PMC: 8426260. DOI: 10.1016/j.intimp.2021.108127. View

Cao Y, Li L, Feng Z, Wan S, Huang P, Sun X . Comparative genetic analysis of the novel coronavirus (2019-nCoV/SARS-CoV-2) receptor ACE2 in different populations. Cell Discov. 2020; 6:11. PMC: 7040011. DOI: 10.1038/s41421-020-0147-1. View

Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z . Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020; 395(10229):1054-1062. PMC: 7270627. DOI: 10.1016/S0140-6736(20)30566-3. View

Karra V, Gumma P, Chowdhury S, Ruttala R, Polipalli S, Chakravarti A . IL-18 polymorphisms in hepatitis B virus related liver disease. Cytokine. 2015; 73(2):277-82. DOI: 10.1016/j.cyto.2015.02.015. View

Yalcin K, Kasapoglu B, Alanli R, Kucukay M, Kosar A . The association of oxygen saturation, tomography findings and D-dimer levels in coronavirus disease 2019 patients. Blood Coagul Fibrinolysis. 2020; 31(8):558-561. DOI: 10.1097/MBC.0000000000000964. View

Haehner A, Draf J, Drager S, de With K, Hummel T . Predictive Value of Sudden Olfactory Loss in the Diagnosis of COVID-19. ORL J Otorhinolaryngol Relat Spec. 2020; 82(4):175-180. PMC: 7360503. DOI: 10.1159/000509143. View

Menni C, Valdes A, Freidin M, Sudre C, Nguyen L, Drew D . Real-time tracking of self-reported symptoms to predict potential COVID-19. Nat Med. 2020; 26(7):1037-1040. PMC: 7751267. DOI: 10.1038/s41591-020-0916-2. View

Velichko A, Huyut M, Belyaev M, Izotov Y, Korzun D . Machine Learning Sensors for Diagnosis of COVID-19 Disease Using Routine Blood Values for Internet of Things Application. Sensors (Basel). 2022; 22(20). PMC: 9610709. DOI: 10.3390/s22207886. View

10.

Chiesa-Estomba C, Lechien J, Saussez S . [The alteration of smell and taste in COVID-19 patients. A diagnostic resource in primary care]. Aten Primaria. 2020; 52(8):592-593. PMC: 7250780. DOI: 10.1016/j.aprim.2020.05.005. View

11.

Sobti R, Sharma V, Abitew A, Berhane N, Mahdi S, Askari M . IL-18 Gene Promoter Region 607C/A Polymorphism in HIV-1 Infected North Indian Population. Balkan J Med Genet. 2013; 14(2):41-8. PMC: 3776698. DOI: 10.2478/v10034-011-0046-8. View

12.

Coutinho L, Oliveira C, Albuquerque P, Mota S, Meneses G, Martins A . Elevated IL-18 predicts poor prognosis in critically ill COVID-19 patients at a Brazilian hospital in 2020-21. Future Microbiol. 2022; 17:1287-1294. PMC: 9488117. DOI: 10.2217/fmb-2022-0057. View

13.

AlBahrani S, Alghamdi M, Zakary N, Jebakumar A, AlZahrani S, ElGezery M . Initial viral cycle threshold values in patients with COVID-19 and their clinical significance. Eur J Med Res. 2022; 27(1):101. PMC: 9237989. DOI: 10.1186/s40001-022-00729-5. View

14.

Friske M, Giannone F, Senger M, Seitz R, Hansson A, Spanagel R . Chronic alcohol intake regulates expression of SARS-CoV2 infection-relevant genes in an organ-specific manner. Alcohol Clin Exp Res (Hoboken). 2023; 47(1):76-86. DOI: 10.1111/acer.14981. View

15.

Huyut M, Ustundag H . Prediction of diagnosis and prognosis of COVID-19 disease by blood gas parameters using decision trees machine learning model: a retrospective observational study. Med Gas Res. 2021; 12(2):60-66. PMC: 8562394. DOI: 10.4103/2045-9912.326002. View

16.

Aksu F, Capan N, Aksu K, Ofluoglu R, Canbakan S, Yavuz B . C-reactive protein levels are raised in stable Chronic obstructive pulmonary disease patients independent of smoking behavior and biomass exposure. J Thorac Dis. 2013; 5(4):414-21. PMC: 3755654. DOI: 10.3978/j.issn.2072-1439.2013.06.27. View

17.

Lechien J, Chiesa-Estomba C, De Siati D, Horoi M, Le Bon S, Rodriguez A . Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study. Eur Arch Otorhinolaryngol. 2020; 277(8):2251-2261. PMC: 7134551. DOI: 10.1007/s00405-020-05965-1. View

18.

Buchan B, Hoff J, Gmehlin C, Perez A, Faron M, Munoz-Price L . Distribution of SARS-CoV-2 PCR Cycle Threshold Values Provide Practical Insight Into Overall and Target-Specific Sensitivity Among Symptomatic Patients. Am J Clin Pathol. 2020; 154(4):479-485. PMC: 7454307. DOI: 10.1093/ajcp/aqaa133. View

19.

Huyut M, Huyut Z, Ilkbahar F, Mertoglu C . What is the impact and efficacy of routine immunological, biochemical and hematological biomarkers as predictors of COVID-19 mortality?. Int Immunopharmacol. 2022; 105:108542. PMC: 8761578. DOI: 10.1016/j.intimp.2022.108542. View

20.

Mertoglu C, Huyut M, Arslan Y, Ceylan Y, Coban T . How do routine laboratory tests change in coronavirus disease 2019?. Scand J Clin Lab Invest. 2020; 81(1):24-33. DOI: 10.1080/00365513.2020.1855470. View